RATIO-MPA DIN 02148560
Status: Cancelled Post Market
Holder: RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
Molecule: MEDROXYPROGESTERONE ACETATE
Health Canada record
| Active ingredient(s) | MEDROXYPROGESTERONE ACETATE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03DA02 MEDROXYPROGESTERONE |
| Original market date | 17-Jul-1996 |
| Current status date | 01-Aug-2008 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MEDROXYPROGESTERONE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02244727 | AA-MEDROXY | AA PHARMA INC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Marketed |
| 02244726 | AA-MEDROXY | AA PHARMA INC | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Marketed |
| 02277298 | AA-MEDROXY | AA PHARMA INC | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Marketed |
| 02267640 | AA-MEDROXY | AA PHARMA INC | Tablet | MEDROXYPROGESTERONE ACETATE 100 MG | Marketed |
| 02523493 | DEPO-PROVERA | PFIZER CANADA ULC | Suspension | MEDROXYPROGESTERONE ACETATE 150 MG | Marketed |
| 02519062 | TARO-MEDROXYPROGESTERONE INJECTION | TARO PHARMACEUTICALS INC | Suspension | MEDROXYPROGESTERONE ACETATE 150 MG | Approved |
| 02221292 | TEVA-MEDROXYPROGESTERONE | TEVA CANADA LIMITED | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Marketed |
| 02221306 | TEVA-MEDROXYPROGESTERONE | TEVA CANADA LIMITED | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Marketed |
| 02221284 | TEVA-MEDROXYPROGESTERONE | TEVA CANADA LIMITED | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Marketed |
| 00030848 | DEPO-PROVERA | PFIZER CANADA ULC | Suspension | MEDROXYPROGESTERONE ACETATE 50 MG | Cancelled Post Market |
| 00585092 | DEPO-PROVERA | PFIZER CANADA ULC | Suspension | MEDROXYPROGESTERONE ACETATE 150 MG | Cancelled Post Market |
| 02247582 | DOM-MEDROXYPROGESTERONE | DOMINION PHARMACAL | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02247581 | DOM-MEDROXYPROGESTERONE | DOMINION PHARMACAL | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02247583 | DOM-MEDROXYPROGESTERONE | DOMINION PHARMACAL | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 02229840 | GEN-MEDROXY TABLET 10MG | GENPHARM ULC | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 02229838 | GEN-MEDROXY TABLET 2.5MG | GENPHARM ULC | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02229839 | GEN-MEDROXY TABLET 5MG | GENPHARM ULC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02253550 | MEDROXY-2.5 | PRO DOC LIMITEE | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02253577 | MEDROXY-5 | PRO DOC LIMITEE | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02322250 | MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP | SANDOZ CANADA INCORPORATED | Suspension | MEDROXYPROGESTERONE ACETATE 150 MG | Cancelled Post Market |
| 02212056 | MEPROGEST | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Pre Market |
| 02212064 | MEPROGEST | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Pre Market |
| 02212072 | MEPROGEST | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Pre Market |
| 02252759 | NU-MEDROXY | NU-PHARM INC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled (Unreturned Annual) |
| 02252740 | NU-MEDROXY | NU-PHARM INC | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled (Unreturned Annual) |
| 02231769 | PENTA-MEDROXYPROGESTERONE TABLETS | PENTAPHARM LTD. | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02231768 | PENTA-MEDROXYPROGESTERONE TABLETS | PENTAPHARM LTD. | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02231770 | PENTA-MEDROXYPROGESTERONE TABLETS | PENTAPHARM LTD. | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 02246627 | PMS-MEDROXYPROGESTERONE | PHARMASCIENCE INC | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02246628 | PMS-MEDROXYPROGESTERONE | PHARMASCIENCE INC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02246629 | PMS-MEDROXYPROGESTERONE | PHARMASCIENCE INC | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 02239825 | PROCLIM | FOURNIER PHARMA INC | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02239826 | PROCLIM | FOURNIER PHARMA INC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02239827 | PROCLIM | FOURNIER PHARMA INC | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 00030945 | PROVERA 100MG TABLETS | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 100 MG | Cancelled Post Market |
| 00729973 | PROVERA 10MG TABLETS | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 00708917 | PROVERA 2.5MG TABLETS | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 00030937 | PROVERA 5MG TABLETS | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02010933 | PROVERA PAK 10MG TABLETS | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 02010739 | PROVERA PAK 5MG TABLETS | PFIZER CANADA ULC | Tablet | MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02148552 | RATIO-MPA | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02148579 | RATIO-MPA | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Post Market |
| 00813583 | VERAMIX SPONGES | PHARMACIA ANIMAL HEALTH | Sponge | MEDROXYPROGESTERONE ACETATE 60 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 691 | 2002-05-01 | New Drug Submission (NDS) | MANUFACTURER AND PRODUCT NAME CHANGE |
| 4530 | 1996-10-04 | New Drug Submission (NDS) | |
| 5157 | 1995-01-24 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE, REVISED PRODUCT MONOGRAPH |
International API supply for MEDROXYPROGESTERONE ACETATE
5 valid EDQM Certificates of Suitability from 5 holders. 11 active FDA Drug Master Files.
Request a quote for RATIO-MPA